CA
PRAH

CXI Advisors’s PRA Health Sciences, Inc. PRAH Stock Holding History

CXI Advisors’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$8K Buy
+68
New +$7K 0.02% 136

Other funds holding PRAH

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return

CXI Advisors's PRAH Position: Q4 2019 in Review

CXI Advisors opened a new position in PRA Health Sciences, Inc. (PRAH) in Q4 2019: 68 shares worth $8K. The stake represents 0.02% of the portfolio and ranks #136 among its holdings.

345 funds tracked by Wall St. Rank hold PRAH as of Q4 2019.

  • CXI Advisors held 68 shares of PRA Health Sciences, Inc. worth $8K as of Q4 2019.
  • PRA Health Sciences, Inc. was a new CXI Advisors position in Q4 2019.
  • PRA Health Sciences, Inc. made up 0.02% of CXI Advisors's portfolio in Q4 2019, its #136 holding.
  • 345 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2019.

Based on CXI Advisors's 13F filing for Q4 2019, filed 27 Jan 2020.